Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 11/06/2026Did you make a connection at #EACR2026? 👀⬇️ 033
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 11/06/2026What a wonderful week we’ve had here together in Budapest for #EACR2026! Thank you to everyone who attended, presented at and helped organise this fantastic event. Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=... 091
George Sflomos @georgesflomos.bsky.social · 11/06/2026Amazing session! Congrats for the active participation! 020
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 08/06/2026We’re so proud to showcase the next wave of talent in cancer research at our ‘Cancer Researchers to watch’ early career showcase yesterday and this morning. #EACR2026 121
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 08/06/2026Today is the start of #EACR2026! We’re excited to welcome participants from over 70 countries to our Annual Congress here in Budapest. Find the programme at 2026.eacr.org and don’t forget to use the hashtag! 042
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 08/06/2026As we open the #EACR2026 Congress Marisol Soengas @msmelanoma.bsky.social delivers a moving talk on the importance of the patient perspective in research. 093
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 09/06/2026Our early career and student participants are learning from cancer research leaders this afternoon on topics from ‘How to build your own network’ to ‘How to make smart career choices’! Fantastic to see all the new connections being made at #EACR2026 082
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 09/06/2026Charles Swanton delivers the Mike Price Award Lecture on ‘Cancer Promotion and Preventing Pathologies of Ageing’ this afternoon at #EACR2026 👏 0153
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 10/06/2026We’re delighted to have awarded 52 Travel Grants to help researchers from 26 countries to attend #EACR2026 – congratulations to all of you! 051
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 10/06/2026Today’s Plenary Session “From Bench to Bedside and Back” features talks from Johanna A Joyce, Yardena Samuels, Gideon Bollag, Darrin Stuart, and Keith Flaherty. #EACR2026 0113
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 04/06/2026Don't forget that the EACR-Worldwide Cancer Research Collaboration Fellowships are a new initiative this year. If you make a new research connection at EACR 2026, apply for funding to continue the collaboration with an in-person visit! Apply by 3 Sep 2026 eacr.org/collaboratio... 023
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 01/06/2026We're counting down the days until #EACR2026 in Budapest! With participants from over 70 countries, intentional programming, and several networking events - you're bound to leave inspired for the next stage of your research. There's still time to join us! Find more information at 2026.eacr.org 132
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 02/06/2026Nominations are now open for the: 🏆Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award 🏆Pezcoller Foundation-EACR Translational Cancer Researcher Award Nominating someone is a great way to recognise and celebrate their achievements. For more information: eacr.org/pezcoller-fo... 055
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 30/04/2026The EACR Congress is coming to Hungary in June! Join the wider cancer research community in Budapest for four days of fantastic science and networking opportunities at #EACR2026 🤝 Register before 18 May to get the regular rate! 👀 Learn more here ➡️ 2026.eacr.org 022
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 12/05/2026Our Cancer Genomics conference is happening today with an introduction by Carlos Caldas, Chair of the Scientific Programme Committee! 0144
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 22/05/2026Introducing the EACR-Worldwide Cancer Research Collaboration Fellowships! If you make a new research connection at the EACR 2026 Congress in Budapest, why not apply for funding for an in-person visit? Applications due by 03 September 2026 Apply here: eacr.org/collaboratio... 021
George Sflomos @georgesflomos.bsky.social · 02/05/2026Excited to start at HUG in Geneva, bridging translational oncology and radiotherapy! 010
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 14/04/2026How can researchers and patient advocates actually work together — and what does meaningful collaboration look like in practice? Episode 31 of The Cancer Researcher Podcast tackles this topic head-on. Listen now: magazine.eacr.org/an-open-foru... 🎧 031
Reposted by George SflomosCaldas Lab 🇵🇹🇮🇱🇪🇺🇬🇧 @caldaslab.bsky.social · 13/04/2026PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer! This started with the RATHER project, which was part of the EU's FP VII funded (cordis.europa.eu/project/id/2...) @caldaslab.bsky.social always walked the walk! aacrjournals.org/clincancerre...aacrjournals.orgPI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA ResultsAbstractPurpose:. To determine the safety and efficacy of taselisib, a selective PI3K inhibitor, in combination with tamoxifen.Patients and Methods:. POSEIDON is a phase II, randomized, placebo-contro... 143
Reposted by George SflomosBreast Cancer Now @breastcancernow.bsky.social · 23/03/2026We're researching relentlessly now. For a future where no one dies of breast cancer. 🔬 We're here with support now. Until the day you no longer need us. ❤️ We're demanding change now. So everyone can get the best treatment. 📢 194
George Sflomos @georgesflomos.bsky.social · 22/03/2026Terrific study! This review will be a super useful tool to people working with preclinical models! oncodaily.com/voices/patri...oncodaily.comPatrick Aouad: Major Preclinical Models Used to Study Breast Cancer Metastasis - OncoDailyPatrick Aouad: Major Preclinical Models Used to Study Breast Cancer Metastasis / Berthe Hayar, cancer, Cathrin Brisken, Ciara Metcalfe, George Sflomos, Karim 021
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 23/02/2026You have until 16 March to apply for travel grants and submit abstracts for Cancer Genomics, Multiomics and Computational Biology! This extremely popular EACR conference showcases the latest breakthroughs in this exciting field with a cutting-edge programme.eacr.orgIntroduction | Cancer Genomics, Multiomics and Computational Biology | The European Association for Cancer ResearchKey dates 024
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 11/03/2026Who should attend our FREE public webinar with the @CGIclinics project? 👉️ Clinical molecular biologists & pathologists 👉️ Oncologists in precision medicine & phase I clinical trials 👉️ Researchers in precision oncology & cancer genomics 👉️ Bioinformaticians in clinical oncology labs buff.ly/KQL1KDS 014
George Sflomos @georgesflomos.bsky.social · 17/03/2026Super useful tool to people working with preclinical models! Terrific work @patrickaouad.bsky.social summarising decades of research to provide a review on the major preclinical models used to study breast cancer metastasis. 000
Reposted by George SflomosEMBO @embo.org · 04/03/2026Sign up by 6 March for the EMBO Lab Leadership #training "How to write a scientific paper" delivered by EMBO Press editors at EMBO | EMBL Symposium "#AI and #biology." 🧪 www.embl.org/about/info/course-and-… #EESAIBio #EMBOevents 074
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 19/02/2026Have you submitted your abstract yet for #EACR2026 Congress (Budapest, 8-11 June)? Don't miss the exciting opportunity to showcase your research and build new connections and collaborations with the global cancer research community. You have until 04 March to get your submissions in: 2026.eacr.org2026.eacr.orgEACR 2026 Congress: Innovative Cancer Science | EACR2026 026
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 27/02/2026Are you an early career researcher attending #EACR2026 in Budapest this June? You may be eligible to attend our FREE early career showcase, Cancer Researchers to Watch, taking place 7-8 June! Learn more:2026.eacr.orgCancer Researchers to Watch - An Early Career Showcase | EACR2026The Early Career Showcase in Budapest at EACR 2026, taking place on 07-08 June, will bring together the next generation of cancer researchers for two days of scientific exchange and community building.... 022
Reposted by George SflomosJohn Prensner @johnprensner.bsky.social · 12/02/2026All- don't miss the chance to register for the European Association for Cancer Research meeting in Budapest in June. I'll be there if you want to chat about all things microproteins! #EACR #CancerResearch 052
George Sflomos @georgesflomos.bsky.social · 14/01/2026EACR Career Masterclass 2026 website is now live! An exceptional virtual programme for early-career cancer researchers with practical career insights. 🗓 17–18 November 2026 | 🌍 Online eacr.org/conference/c... #EACR #CancerResearch #EarlyCareerResearcherseacr.orgIntroduction | Career Masterclass for Early Career Cancer Researchers | The European Association for Cancer Research 011
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 26/12/2025Got some down time before the New Year? Catch up with The Cancer Researcher Podcast, where we dive into the inspiring and challenging world of being a cancer researcher. Explore topics from navigating imposter syndrome to mastering scientific communication: magazine.eacr.org/podcast/ 064
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 07/01/2026Registration is now OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org 036
George Sflomos @georgesflomos.bsky.social · 22/12/2025I was pleased to contribute as a speaker to the first European Association for Cancer Research (EACR) – Organisation of European Cancer Institutes (OECI) virtual event on Patient Involvement in Cancer Research. 010
Reposted by George SflomosKristian Pietras lab @kpietraslab.bsky.social · 22/12/2025Check this out👇 Our neighbors @pietraslab.bsky.social has just published a new preprint detailing high-resolution profiling of the irradiated GBM microenvironment. ❄️Cool reading for the holidays❄️ Thanks for including us! 082
Reposted by George SflomosNature @nature.com · 04/12/2025Nature research paper: Whole-genome landscapes of 1,364 breast cancers go.nature.com/48PM7Orgo.nature.comWhole-genome landscapes of 1,364 breast cancers - NatureWhole-genome and transcriptome analysis of 1,364 cases of breast cancer from South Korea broadens our understanding of breast cancer biology and reveals genomic features that connect tumour biology with treatment responses and clinical outcomes. 1185
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 18/11/2025Registration for our next edition of Liquid Biopsies is now open 🎉 Join world-leading experts and emerging investigators to explore the latest advances in circulating nucleic acids, circulating tumour cells & extracellular vesicles across the cancer continuum. eacr.org/conference/l... 032
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 21/11/2025You have until 15 December to register for our upcoming virtual conference! We will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways. Register from €60: eacr.org/conference/o... 053
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 24/09/2025There's no better day than #WorldCancerResearchDay to register for our next virtual conference, Patient Involvement in Cancer Research! Learn how to make your research better and more impactful. Registration closes on Monday. Learn more: eacr.org/conference/p... 042
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 04/09/2025EACR members! Join us for an interactive workshop on scientific publishing, where expert scientific editors will guide you through the essential steps of getting your research into the academic spotlight. 📅 29 September, 14:00-15:30 CEST 🌍 Zoom us02web.zoom.us/meeting/regi... 034
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 17/09/2025Stand out in your career & boost your research impact 💥 Funders & journals now expect real patient involvement. Join this event to get practical insights to collaborate better & future-proof your research. Registration closes 29 Sept - don’t miss it! 👉 eacr.org/conference/p... 023
Reposted by George SflomosJames Briscoe @jamesbriscoe.bsky.social · 02/12/2024New @dev-journal.bsky.social editorial We know we have high standards - but we're committed to making publishing with us constructive From clear revision guidance to limitations sections & transparent peer review, we're here to help you share your science journals.biologists.com/dev/article/...journals.biologists.comConstructive Critics: Development's approach to peer reviewWe're all familiar with complaints about peer review. Some think it's biased – editors (especially from ‘those’ journals) seem to have too much power to decide what gets published. It can be opaque – ... 311546
Reposted by George SflomosNature Portfolio @natureportfolio.nature.com · 08/09/2025Nature Careers reports on how a new generation of researchers are using Substack as a way to build audiences and monetize their knowledge. #Academicsky 🧪 go.nature.comWhy scientists are flocking to SubstackA new generation of researchers is using the platform to build audiences and monetize their knowledge. 086
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 12/03/2025Join us this November in Bergamo to help shape the future of early-onset cancer research! We're excited to bring you this brand new conference topic, exploring the biology, causes and detection of cancer in younger patients. In partnership with @themarkfdn.bsky.social 💙 eacr.org/conference/m... 0149
Reposted by George SflomosWafik S. El-Deiry, MD, PhD, FACP @weldeiry.bsky.social · 21/07/2025Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markers www.cell.com/molecular-ce...cell.comStructural mechanism of H3K27 demethylation and crosstalk with heterochromatin markersChien-Chu Lin et al. reveal the structure of the histone demethylase KDM6B bound to the nucleosome. The study shows how KDM6B is positioned for H3K27 demethylation and how heterochromatin features suc... 011
Reposted by George SflomosMatt Sikora @mjsikora.bsky.social · 25/06/2025We used ~normal human mammary epithelial cells (HMECs) to test CDH1 loss (modeling ILC) vs inhibiting E-cadherin, i.e. genetic suppression vs signaling block, to define how CDH1 loss is fundamentally different that 'simply' losing E-cadh mediated cell contacts. I.e. is this ~EMT, or not? 2/n 121
Reposted by George SflomosMatt Sikora @mjsikora.bsky.social · 25/06/2025As we learn more re CDH1 loss-induced lineage reprogramming, we can develop new risk assessment strategies for benign ILC precursors, build prevention strategies, and target "truncal" effects of CDH1 loss in overt ILC to target the changes that likely are important in every single cancer cell. 5/5 041
Reposted by George SflomosMatt Sikora @mjsikora.bsky.social · 25/06/2025So CDH1 loss causes a lineage remodeling in normal HMEC, locking cells in a new luminal progenitor-like state. This may explain why nearly all ILC are luminal-type (i.e. ER+) and point to CDH1 loss as a critical "bottleneck" in breast oncogenesis specific to ILC. 4/n 151
Reposted by George SflomosMatt Sikora @mjsikora.bsky.social · 25/06/2025We did a thing w @jostrander.bsky.social! Over the last few years, we took a new direction into #lobular breast cancer oncogenesis. We know loss of the gene CDH1 (E-cadherin) is central to ILC, and is among its earliest oncogenic events. But why? How does this push normal breast toward cancer? 1/n 1104
Reposted by George SflomosEACR - European Association for Cancer Research @helloeacr.bsky.social · 14/05/2025🚨 New podcast episode! In this insightful and honest conversation, award winners Karin de Visser, Ido Amit and @martakova.bsky.social talk about their research, career journeys, and excitement for the future of cancer research: magazine.eacr.org/curiosity-op... 0114
Reposted by George SflomosAlexandra Boitor @alexandraboitor.bsky.social · 12/06/2025If you're traveling this weekend (like I will for the EACR Congress in Lisbon) this is a great way to learn something new while waiting on trains and airports. The Cancer Researcher Podcast is available on all major podcast platforms! 061